Here are the 8 trades and 3 price-target changes we made during a busy week

Here are the 8 trades and 3 price-target changes we made during a busy week


Traders work during the opening bell at the New York Stock Exchange (NYSE) on Wall Street in New York City on August 16, 2022.

Angela Weiss | AFP | Getty Images

Our portfolio experienced a flurry of adjustments in a week dominated by Nvidia’s (NVDA) quarterly results Wednesday evening and Federal Reserve Chairman Jerome Powell’s Jackson Hole address Friday.

Here’s a day-by-day look at the trades and price-target changes, and what motivated each decision.



Source

Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Health

Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Competition in […]

Read More
CDC vaccine panel holds first meeting since RFK Jr. put immunization critics in place
Health

CDC vaccine panel holds first meeting since RFK Jr. put immunization critics in place

A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia. Tami Chappell | Reuters A crucial government panel of vaccine advisors will hold its first meeting Wednesday since Health and Human Services Secretary Robert F. Kennedy Jr. appointed several vaccine critics to the group.  Earlier this month, Kennedy in […]

Read More
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Health

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images Novo Nordisk on Monday said it is ending its collaboration with Hims & Hers due to concerns about the telehealth company’s sales […]

Read More